Test3Bank3-3Pharmacology:3A3Patient-Centered3Nursing3Process3Approach3(9th3Edition, 32017)
PHARMACOLOGY39TH3EDITION3MCCUISTION3TEST 3BANK
This3is3a3set3of3questions3to3answer3the3questions3of3the3textbook3"Pharmacology: 3A3Patient-
Centered3Nursing3Process3Approach39th3Edition"3it3helps3you3to3better3understand3the3book3correctly.
Get3the3right3dosage3of3pharmacology3content3to3succeed3on3the3NCLEX3and3as3a3professional3nurs
e3with3"Pharmacology: 3A3Patient-
Centered3Nursing3Process3Approach,39th3Edition".3Using3a3streamlined3prototype3approach3and3an3
emphasis3on3nursing3care,3this3text3makes3it3easy3for3today’s3nursing3students3to3better3understand
3the3complicated3subject3of3pharmacology. 3The3book’s3detailed3chapter3on3dosage3calculation, 3the3n
ursing3process3framework3for3drug3therapy,3strong3QSEN3focus,3and3summaries3of3prototype3drugs
3help3deliver 3the3perfect.
,Test3Bank3-3Pharmacology:3A3Patient-
Centered3Nursing3Process3Approach3(9th3Edition,32017)
PHARMACOLOGY39TH3EDITION3MCCUISTION3TEST3BANK
Table3of3Contents
Table3of3Contents Chapter328:3Peptides,3Antimalarial,3and
Chapter301:3Drug3Development3and3E Anthelmintic
thical3Considerations Chapter329:3HIV-3and3AIDS-
Chapter302:3Pharmacokinetics,3Phar Related3Drugs
macodynamics,3and3Pharmacogeneti Chapter330:3Transplant3Drugs
cs 3Chapter331:3Vaccines3 Chapt
Chapter303:3Cultural3Considerations3 er332:3Anticancer3Drugs
Chapter3 04:3Complementary3and3Alte Chapter333:3Targeted3Therapies3to3Treat3C
rnative3Therapies ancer
Chapter305:3Pediatric3Considerations Chapter334:3Biologic3Response3Modifie
3Chapter306:3Geriatric3Consideration rs
s3Chapter307:3Drugs3in3Substance3U Chapter335:3Upper3Respiratory3Disord
se3Disorder ers
Chapter308:3The3Nursing3Process3an Chapter336:3Lower3Respiratory3Disord
d3Patient-Centered3Care ers
Chapter3 09:3Safety3and3Quality3Chapt Chapter3 37:3Cardiac3Glycosides,3Anti
er310:3Drug3Administration3Chapter31 anginals,3and3Antidysrhythmics3Chapt
1:3Drug3Calculations3Chapter312:3Flui er338:3Diuretics
d3Volume3and3Electrolytes Chapter339:3Antihypertensive
Chapter313:3Vitamin3and3Mineral3Repl Chapter3 40:3Anticoagulants,3Antiplatele
acement ts,3and3Thrombolytics3Chapter 341:3Anti
Chapter3 14:3Nutritional3Support3Chap hyperlipidemics 3and3Peripheral3Vasodil
ter315:3Adrenergic3Agonists3and3Anta ators
gonists Chapter342:3Gastrointestinal3Tract3Dis
Chapter316:3Cholinergic3Agonists3an orders
d3Antagonists Chapter3 43:3Antiulcer3Drugs3 Chapt
Chapter317:3Stimulants er344:3Eye3and3Ear3Disorders3Chap
Chapter3 18:3Depressants3Chapt ter345:3Dermatologic3Disorders3Cha
er319:3Antiseizure 3Drugs pter346:3Pituitary,3Thyroid,3Parathyr
Chapter320:3Drugs3for3Parkinsonism 3and oid,3and3Adrenal3Disorders3Chapter
3Alzheimer's3Disease 347:3Antidiabetics
Chapter321:3Drugs3for3Neuromuscular Chapter3 48:3Urinary3Disorders3Chapt
3Disorders3 and3Muscle3Spasms3Chap er349:3Pregnancy 3and3Preterm3Labor
ter322:3Antipsychotics3and3Anxiolytics Chapter350:3Labor,3Delivery,3and3Post
Chapter323:3Antidepressants3and3Mood3 partum
Stabilizers Chapter 351:3Neonatal3and3Newbor
Chapter324:3Antiinflammatories n3Chapter352:3Women's3Reproducti
Chapter325:3Analgesics ve3Health
Chapter326:3Antibacterials Chapter353:3Men's3Reproductive3Health3C
Chapter327:3Antituberculars,3Antifungals, hapter354:3Sexually3Transmitted3Infections
3and3Antivirals Chapter 355:3Adult3and3Pediatric
,Test3Bank3-3Pharmacology:3A3Patient-
Centered3Nursing3Process3Approach3(9th3Edition,32017)
PHARMACOLOGY39TH3EDITION3MCCUISTION3TEST3BANK
Emergency3Drugs
, Test3Bank3-3Pharmacology:3A3Patient-
Centered3Nursing3Process3Approach3(9th3Edition,32017)
PHARMACOLOGY39TH3EDITION3MCCUISTION3TEST3BANK
Chapter301:3Drug3Development3and3Ethical3Considerations
MULTIPLE3CHOICE
1. The3nurse3is3preparing3to3administer3a3schedule3II3injectable3drug3and 3is3drawing3up3half
3of3the3contents3of3a3Single-use3vial.3Which3nursing3action3is3correct?
a. Ask3another3nurse3to3observe3and3cosign3wasting3the3remaining3drug 3from3the3vial.
b. Keep3the3remaining 3amount3in3the3patient’s3drawer3to3give3at3the3next3dose.
c. Record3the3amount 3unused3in3the3patient’s3medication3record.
d. Dispose3of3the3vial3with3the3remaining3drug3into3a 3locked3collection3bo
x.3ANS:3A
Schedule3II3drugs3are3controlled3substances,3and3all3must3be3accounted 3for.3When3wasting3a3
portion3of3a3drug,3another3nurse3should3observe3and3cosign3that3a3drug3was3wasted.
DIF:3COGNITIVE3LEVEL:3Applying3(Application)3T
OP:3NURSING3PROCESS:3Nursing3Intervention
MSC:3NCLEX:3Physiological3Integrity: 3Pharmacological3and3Parenteral3Therapies
2. A3patient3is3prescribed3a3medication3and3asks3the3nurse3if3the3drug3is3available3in3a3gen
eric3form.3 The3nurse3understands3that3a3generic3medication3will3have3a3name3that
a. is3a3registered3trademark.
b. is3always3capitalized.
c. describes3the3drugs3chemical3structure.
d. is3non-
proprietary.3ANS:3D
The3generic3name3is3the3official,3non-
proprietary3name3for3a3drug.3 The3brand3name3is3the3trademark3name 3and3is3always3capitalized.
3The3chemical3name3describes3the3chemical3structure3of3the3drug.
DIF:3COGNITIVE3LEVEL:3Understanding 3(Comprehension)
3TOP:3NURSING3PROCESS:3N/A
MSC:3NCLEX:3Physiological3Integrity: 3Pharmacological3and3Parenteral3Therapies
3. A3patient3receives3a3prescription3on3which3the3provider3has3noted3that3a3generic3medicati
on3may3be3given.The3patient3asks3the3nurse3what3this3means.3What3will3the3nurse3tell3the3p
atient3about3generic3drugs?
a. They3contain3the3same3inert3ingredients3as3brand-name3drugs.
b. They3have 3chemical3structures3that3are3identical3to3proprietary3drugs.
c. They3tend3to3be3less3expensive3than3brand-name3drugs.
d. They3undergo3extensive3testing3before3they3are3markete
d.3ANS:3C
Generic3drugs3are3approved3by3the3 FDA3if3they3are3proved3to3be3bioequivalent3to3the3brand-
3name3drug.3They3tend3to3be3less3expensive3because3manufacturers3of3these3drugs3do3not3h
ave3to3do3the3extensive3testing3required3of3brand-
name3drugs3before3marketing.3They3are3not3identical3to3brand-
name3drugs3and3often3have3different3inert3ingredients.
DIF:3COGNITIVE3LEVEL:3Applying3(Application)
TOP:3NURSING3PROCESS:3Nursing3Intervention:3Patient3Teaching3M
SC:3NCLEX:3Management3of3Client3Care
4. The3nurse3reviews3information3about3a3drug3and3notes3the3initials3USP3after3the3drugs3offic
ial3name.3The3nurse3understands3that3this3designation3indicates3the3drug
a. is3a3controlled3substance.
PHARMACOLOGY39TH3EDITION3MCCUISTION3TEST 3BANK
This3is3a3set3of3questions3to3answer3the3questions3of3the3textbook3"Pharmacology: 3A3Patient-
Centered3Nursing3Process3Approach39th3Edition"3it3helps3you3to3better3understand3the3book3correctly.
Get3the3right3dosage3of3pharmacology3content3to3succeed3on3the3NCLEX3and3as3a3professional3nurs
e3with3"Pharmacology: 3A3Patient-
Centered3Nursing3Process3Approach,39th3Edition".3Using3a3streamlined3prototype3approach3and3an3
emphasis3on3nursing3care,3this3text3makes3it3easy3for3today’s3nursing3students3to3better3understand
3the3complicated3subject3of3pharmacology. 3The3book’s3detailed3chapter3on3dosage3calculation, 3the3n
ursing3process3framework3for3drug3therapy,3strong3QSEN3focus,3and3summaries3of3prototype3drugs
3help3deliver 3the3perfect.
,Test3Bank3-3Pharmacology:3A3Patient-
Centered3Nursing3Process3Approach3(9th3Edition,32017)
PHARMACOLOGY39TH3EDITION3MCCUISTION3TEST3BANK
Table3of3Contents
Table3of3Contents Chapter328:3Peptides,3Antimalarial,3and
Chapter301:3Drug3Development3and3E Anthelmintic
thical3Considerations Chapter329:3HIV-3and3AIDS-
Chapter302:3Pharmacokinetics,3Phar Related3Drugs
macodynamics,3and3Pharmacogeneti Chapter330:3Transplant3Drugs
cs 3Chapter331:3Vaccines3 Chapt
Chapter303:3Cultural3Considerations3 er332:3Anticancer3Drugs
Chapter3 04:3Complementary3and3Alte Chapter333:3Targeted3Therapies3to3Treat3C
rnative3Therapies ancer
Chapter305:3Pediatric3Considerations Chapter334:3Biologic3Response3Modifie
3Chapter306:3Geriatric3Consideration rs
s3Chapter307:3Drugs3in3Substance3U Chapter335:3Upper3Respiratory3Disord
se3Disorder ers
Chapter308:3The3Nursing3Process3an Chapter336:3Lower3Respiratory3Disord
d3Patient-Centered3Care ers
Chapter3 09:3Safety3and3Quality3Chapt Chapter3 37:3Cardiac3Glycosides,3Anti
er310:3Drug3Administration3Chapter31 anginals,3and3Antidysrhythmics3Chapt
1:3Drug3Calculations3Chapter312:3Flui er338:3Diuretics
d3Volume3and3Electrolytes Chapter339:3Antihypertensive
Chapter313:3Vitamin3and3Mineral3Repl Chapter3 40:3Anticoagulants,3Antiplatele
acement ts,3and3Thrombolytics3Chapter 341:3Anti
Chapter3 14:3Nutritional3Support3Chap hyperlipidemics 3and3Peripheral3Vasodil
ter315:3Adrenergic3Agonists3and3Anta ators
gonists Chapter342:3Gastrointestinal3Tract3Dis
Chapter316:3Cholinergic3Agonists3an orders
d3Antagonists Chapter3 43:3Antiulcer3Drugs3 Chapt
Chapter317:3Stimulants er344:3Eye3and3Ear3Disorders3Chap
Chapter3 18:3Depressants3Chapt ter345:3Dermatologic3Disorders3Cha
er319:3Antiseizure 3Drugs pter346:3Pituitary,3Thyroid,3Parathyr
Chapter320:3Drugs3for3Parkinsonism 3and oid,3and3Adrenal3Disorders3Chapter
3Alzheimer's3Disease 347:3Antidiabetics
Chapter321:3Drugs3for3Neuromuscular Chapter3 48:3Urinary3Disorders3Chapt
3Disorders3 and3Muscle3Spasms3Chap er349:3Pregnancy 3and3Preterm3Labor
ter322:3Antipsychotics3and3Anxiolytics Chapter350:3Labor,3Delivery,3and3Post
Chapter323:3Antidepressants3and3Mood3 partum
Stabilizers Chapter 351:3Neonatal3and3Newbor
Chapter324:3Antiinflammatories n3Chapter352:3Women's3Reproducti
Chapter325:3Analgesics ve3Health
Chapter326:3Antibacterials Chapter353:3Men's3Reproductive3Health3C
Chapter327:3Antituberculars,3Antifungals, hapter354:3Sexually3Transmitted3Infections
3and3Antivirals Chapter 355:3Adult3and3Pediatric
,Test3Bank3-3Pharmacology:3A3Patient-
Centered3Nursing3Process3Approach3(9th3Edition,32017)
PHARMACOLOGY39TH3EDITION3MCCUISTION3TEST3BANK
Emergency3Drugs
, Test3Bank3-3Pharmacology:3A3Patient-
Centered3Nursing3Process3Approach3(9th3Edition,32017)
PHARMACOLOGY39TH3EDITION3MCCUISTION3TEST3BANK
Chapter301:3Drug3Development3and3Ethical3Considerations
MULTIPLE3CHOICE
1. The3nurse3is3preparing3to3administer3a3schedule3II3injectable3drug3and 3is3drawing3up3half
3of3the3contents3of3a3Single-use3vial.3Which3nursing3action3is3correct?
a. Ask3another3nurse3to3observe3and3cosign3wasting3the3remaining3drug 3from3the3vial.
b. Keep3the3remaining 3amount3in3the3patient’s3drawer3to3give3at3the3next3dose.
c. Record3the3amount 3unused3in3the3patient’s3medication3record.
d. Dispose3of3the3vial3with3the3remaining3drug3into3a 3locked3collection3bo
x.3ANS:3A
Schedule3II3drugs3are3controlled3substances,3and3all3must3be3accounted 3for.3When3wasting3a3
portion3of3a3drug,3another3nurse3should3observe3and3cosign3that3a3drug3was3wasted.
DIF:3COGNITIVE3LEVEL:3Applying3(Application)3T
OP:3NURSING3PROCESS:3Nursing3Intervention
MSC:3NCLEX:3Physiological3Integrity: 3Pharmacological3and3Parenteral3Therapies
2. A3patient3is3prescribed3a3medication3and3asks3the3nurse3if3the3drug3is3available3in3a3gen
eric3form.3 The3nurse3understands3that3a3generic3medication3will3have3a3name3that
a. is3a3registered3trademark.
b. is3always3capitalized.
c. describes3the3drugs3chemical3structure.
d. is3non-
proprietary.3ANS:3D
The3generic3name3is3the3official,3non-
proprietary3name3for3a3drug.3 The3brand3name3is3the3trademark3name 3and3is3always3capitalized.
3The3chemical3name3describes3the3chemical3structure3of3the3drug.
DIF:3COGNITIVE3LEVEL:3Understanding 3(Comprehension)
3TOP:3NURSING3PROCESS:3N/A
MSC:3NCLEX:3Physiological3Integrity: 3Pharmacological3and3Parenteral3Therapies
3. A3patient3receives3a3prescription3on3which3the3provider3has3noted3that3a3generic3medicati
on3may3be3given.The3patient3asks3the3nurse3what3this3means.3What3will3the3nurse3tell3the3p
atient3about3generic3drugs?
a. They3contain3the3same3inert3ingredients3as3brand-name3drugs.
b. They3have 3chemical3structures3that3are3identical3to3proprietary3drugs.
c. They3tend3to3be3less3expensive3than3brand-name3drugs.
d. They3undergo3extensive3testing3before3they3are3markete
d.3ANS:3C
Generic3drugs3are3approved3by3the3 FDA3if3they3are3proved3to3be3bioequivalent3to3the3brand-
3name3drug.3They3tend3to3be3less3expensive3because3manufacturers3of3these3drugs3do3not3h
ave3to3do3the3extensive3testing3required3of3brand-
name3drugs3before3marketing.3They3are3not3identical3to3brand-
name3drugs3and3often3have3different3inert3ingredients.
DIF:3COGNITIVE3LEVEL:3Applying3(Application)
TOP:3NURSING3PROCESS:3Nursing3Intervention:3Patient3Teaching3M
SC:3NCLEX:3Management3of3Client3Care
4. The3nurse3reviews3information3about3a3drug3and3notes3the3initials3USP3after3the3drugs3offic
ial3name.3The3nurse3understands3that3this3designation3indicates3the3drug
a. is3a3controlled3substance.
